anti cii igg1  (Chondrex Inc)


Bioz Verified Symbol Chondrex Inc is a verified supplier
Bioz Manufacturer Symbol Chondrex Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Chondrex Inc anti cii igg1
    The effect of berberine on circulating anti-bovine type II collagen <t>(CII)</t> IgG in the CIA model. ( A ) Anti-CII <t>IgG1,</t> IgG2a, and total IgG at day 28 among all mice (arthritic and non-arthritic) within BBR, PBS (vehicle control), CIA (no treatment control), and non-CIA control animals ( n = 10 per group). ( B ) Anti-CII IgG levels at day 28 compared among arthritic mice only (BBR n = 5; PBS n = 9; CIA n = 9). Statistical comparisons made with the Kruskal–Wallis test with Dunn’s multiple comparisons. ( C ) Anti-CII IgG levels at day 28 compared among BBR-treated mice who developed arthritis (“arthritic”) vs. those that did not (“non-arthritic”). Statistical comparisons made with the Mann–Whitney U test. For all statistical tests in A–C, * p < 0.05, ** p < 0.01, **** p < 0.0001.
    Anti Cii Igg1, supplied by Chondrex Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cii igg1/product/Chondrex Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti cii igg1 - by Bioz Stars, 2024-02
    86/100 stars

    Images

    1) Product Images from "Berberine Delays Onset of Collagen-Induced Arthritis through T Cell Suppression"

    Article Title: Berberine Delays Onset of Collagen-Induced Arthritis through T Cell Suppression

    Journal: International Journal of Molecular Sciences

    doi: 10.3390/ijms22073522

    The effect of berberine on circulating anti-bovine type II collagen (CII) IgG in the CIA model. ( A ) Anti-CII IgG1, IgG2a, and total IgG at day 28 among all mice (arthritic and non-arthritic) within BBR, PBS (vehicle control), CIA (no treatment control), and non-CIA control animals ( n = 10 per group). ( B ) Anti-CII IgG levels at day 28 compared among arthritic mice only (BBR n = 5; PBS n = 9; CIA n = 9). Statistical comparisons made with the Kruskal–Wallis test with Dunn’s multiple comparisons. ( C ) Anti-CII IgG levels at day 28 compared among BBR-treated mice who developed arthritis (“arthritic”) vs. those that did not (“non-arthritic”). Statistical comparisons made with the Mann–Whitney U test. For all statistical tests in A–C, * p < 0.05, ** p < 0.01, **** p < 0.0001.
    Figure Legend Snippet: The effect of berberine on circulating anti-bovine type II collagen (CII) IgG in the CIA model. ( A ) Anti-CII IgG1, IgG2a, and total IgG at day 28 among all mice (arthritic and non-arthritic) within BBR, PBS (vehicle control), CIA (no treatment control), and non-CIA control animals ( n = 10 per group). ( B ) Anti-CII IgG levels at day 28 compared among arthritic mice only (BBR n = 5; PBS n = 9; CIA n = 9). Statistical comparisons made with the Kruskal–Wallis test with Dunn’s multiple comparisons. ( C ) Anti-CII IgG levels at day 28 compared among BBR-treated mice who developed arthritis (“arthritic”) vs. those that did not (“non-arthritic”). Statistical comparisons made with the Mann–Whitney U test. For all statistical tests in A–C, * p < 0.05, ** p < 0.01, **** p < 0.0001.

    Techniques Used: MANN-WHITNEY

    anti cii igg1  (Chondrex Inc)


    Bioz Verified Symbol Chondrex Inc is a verified supplier
    Bioz Manufacturer Symbol Chondrex Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Chondrex Inc anti cii igg1
    A. <t>Anti-CII</t> <t>IgG1,</t> IgG2a, and total IgG at day 28 among all mice (arthritic and non-arthritic) within BBR, PBS (vehicle control), CIA (no treatment control), and non-CIA control animals (n=12 per group). B. Anti-CII IgG levels at day 28 compared among arthritic mice only (BBR n=5; PBS n=10; CIA n=11). Statistical comparisons made with the Kruskal-Wallis test with Dunn’s multiple comparisons (*p<0.05). C. Anti-CII IgG levels at day 28 compared among arthritic vs. non-arthritic mice who were treated with BBR. Statistical comparisons made with the Mann-Whitney U test (*p<0.05).
    Anti Cii Igg1, supplied by Chondrex Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cii igg1/product/Chondrex Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti cii igg1 - by Bioz Stars, 2024-02
    86/100 stars

    Images

    1) Product Images from "Berberine delays onset of collagen induced arthritis through T cell suppression"

    Article Title: Berberine delays onset of collagen induced arthritis through T cell suppression

    Journal: bioRxiv

    doi: 10.1101/736264

    A. Anti-CII IgG1, IgG2a, and total IgG at day 28 among all mice (arthritic and non-arthritic) within BBR, PBS (vehicle control), CIA (no treatment control), and non-CIA control animals (n=12 per group). B. Anti-CII IgG levels at day 28 compared among arthritic mice only (BBR n=5; PBS n=10; CIA n=11). Statistical comparisons made with the Kruskal-Wallis test with Dunn’s multiple comparisons (*p<0.05). C. Anti-CII IgG levels at day 28 compared among arthritic vs. non-arthritic mice who were treated with BBR. Statistical comparisons made with the Mann-Whitney U test (*p<0.05).
    Figure Legend Snippet: A. Anti-CII IgG1, IgG2a, and total IgG at day 28 among all mice (arthritic and non-arthritic) within BBR, PBS (vehicle control), CIA (no treatment control), and non-CIA control animals (n=12 per group). B. Anti-CII IgG levels at day 28 compared among arthritic mice only (BBR n=5; PBS n=10; CIA n=11). Statistical comparisons made with the Kruskal-Wallis test with Dunn’s multiple comparisons (*p<0.05). C. Anti-CII IgG levels at day 28 compared among arthritic vs. non-arthritic mice who were treated with BBR. Statistical comparisons made with the Mann-Whitney U test (*p<0.05).

    Techniques Used: MANN-WHITNEY